Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Hong Kong · Delayed Price · Currency is HKD 36.08
-0.62 (-1.69%)
Dec 31, 2025, 12:08 PM HKT
HKG:3692 Market Cap
HKG:3692 has a market cap or net worth of 218.43 billion as of December 31, 2025. Its market cap has increased by 98.53% in one year.
Market Cap
218.43B
Enterprise Value
188.84B
Revenue
14.45B
Ranking
n/a
PE Ratio
41.00
Stock Price
36.08
Market Cap Chart
Since June 14, 2019, HKG:3692's market cap has increased from 111.27B to 218.43B, an increase of 96.31%. That is a compound annual growth rate of 10.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 218.43B | 113.01% |
| Dec 31, 2024 | 102.55B | 9.84% |
| Dec 29, 2023 | 93.36B | 6.25% |
| Dec 30, 2022 | 87.86B | -21.92% |
| Dec 31, 2021 | 112.52B | -49.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 266.95B |
| JD Health International | 181.32B |
| Innovent Biologics | 131.21B |
| WuXi Biologics | 129.79B |
| Sino Biopharmaceutical | 110.48B |
| Akeso | 102.52B |
| CSPC Pharmaceutical Group | 97.18B |
| Sichuan Kelun-Biotech Biopharmaceutical | 93.09B |